Techno Blender
Digitally Yours.
Browsing Tag

Gilead

U.S loses HIV patent suit against Gilead Sciences over PrEP

The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020.Mike Blake | ReutersA Delaware federal court jury on Tuesday cleared Gilead Sciences of civil claims by the U.S. government that the company violated patents held by the Centers for Disease and Prevention for an HIV prevention drug.The government sued Gilead in 2019, arguing that the company was profiting off CDC patents through the company's sales of Truvada and Descovy, oral medications taken to prevent HIV infection.But…

Gilead, U.S. fight in court over HIV prevention drug

Gilead Sciences logo displayed on a laptop screen and medical pills are seen in this illustration photo taken in Krakow, Poland on October 18, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images)Nurphoto | Nurphoto | Getty ImagesGilead Sciences and the U.S. government faced off in court Tuesday in the first day of a trial that will probe allegations that the drugmaker violated patents for a crucial HIV prevention drug regimen.The U.S. is trying to enforce four patents issued to the Centers for Disease Control and…

Gilead Sciences, Moderna, Tesla and more

A sign is posted in front of the Gilead Sciences headquarters on April 29, 2020 in Foster City, California.Justin Sullivan | Getty ImagesCheck out the companies making the biggest moves midday:General Mills — General Mills dropped 4.2%, despite reporting better-than-expected revenue and profit for the last quarter. The food producer also raised its full-year forecast. Higher prices partially offset increased output costs.Gilead Sciences — Gilead Sciences sank 2.4% after announcing its Kite unit would acquire biotech…

Bristol-Myers Squibb, Twitter, Gilead Sciences and more

Check out the companies making the biggest moves midday Monday:Gilead Sciences — Shares of Gilead rose 3.8% after the biopharmaceutical company revealed it settled a patent case over its HIV therapies with five generic drugmakers.Twitter — Shares of Twitter slipped 2% after the company said in a regulatory filing that Elon Musk's latest attempt to cancel the deal to buy the social media group is invalid. Most recently, Musk attempted to terminate the purchase citing Twitter's treatment of a whistleblower.Carvana — Carvana…